LPL Financial’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-13,375
| Closed | -$40.7K | – | 5385 |
|
|
2024
Q4 | $40.7K | Sell |
13,375
-29,530
| -69% | -$89.8K | ﹤0.01% | 5002 |
|
|
2024
Q3 | $223K | Sell |
42,905
-7,220
| -14% | -$37.5K | ﹤0.01% | 4562 |
|
|
2024
Q2 | $129K | Buy |
50,125
+2,132
| +4% | +$5.48K | ﹤0.01% | 4587 |
|
|
2024
Q1 | $236K | Buy |
47,993
+8,796
| +22% | +$43.3K | ﹤0.01% | 4310 |
|
|
2023
Q4 | $345K | Buy |
39,197
+16,403
| +72% | +$144K | ﹤0.01% | 3932 |
|
|
2023
Q3 | $261K | Sell |
22,794
-978
| -4% | -$11.2K | ﹤0.01% | 3989 |
|
|
2023
Q2 | $602K | Buy |
23,772
+1,386
| +6% | +$35.1K | ﹤0.01% | 3244 |
|
|
2023
Q1 | $721K | Buy |
22,386
+8,363
| +60% | +$269K | ﹤0.01% | 3015 |
|
|
2022
Q4 | $259K | Sell |
14,023
-13,321
| -49% | -$246K | ﹤0.01% | 3755 |
|
|
2022
Q3 | $738K | Buy |
27,344
+14,001
| +105% | +$378K | ﹤0.01% | 2777 |
|
|
2022
Q2 | $184K | Buy |
13,343
+3,090
| +30% | +$42.6K | ﹤0.01% | 3954 |
|
|
2022
Q1 | $200K | Buy |
+10,253
| New | +$200K | ﹤0.01% | 3811 |
|
|
2021
Q4 | – | Sell |
-19,347
| Closed | -$539K | – | 4441 |
|
|
2021
Q3 | $539K | Sell |
19,347
-6,805
| -26% | -$190K | ﹤0.01% | 3137 |
|
|
2021
Q2 | $775K | Sell |
26,152
-3,342
| -11% | -$99K | ﹤0.01% | 2775 |
|
|
2021
Q1 | $824K | Sell |
29,494
-1,497
| -5% | -$41.8K | ﹤0.01% | 2563 |
|
|
2020
Q4 | $878K | Sell |
30,991
-9,893
| -24% | -$280K | ﹤0.01% | 2282 |
|
|
2020
Q3 | $1.03M | Buy |
40,884
+1,190
| +3% | +$29.9K | ﹤0.01% | 1922 |
|
|
2020
Q2 | $969K | Buy |
+39,694
| New | +$969K | ﹤0.01% | 1835 |
|